Human ACAT1 cDNA K1 was first cloned and functionally expressed in 1993. There are two adjacent in-frame AUG
position within Kozak sequence is the purine (usually A) in the -3 position (3 nt before the codon AUG which is numbered +1 to +3). Mutations affecting A in the -3 position (A   -3 ) strongly impair initiation in vivo and in vitro [8] . Furthermore, the G in the +4 position (G +4 ) is also highly conserved and contributes strongly, especially in the absence of A -3 [9] . In addition, the rest of the GCCRCCaugG motif varies and contributes partially for translation initiation, especially when both the purine in the -3 position and G in the +4 position are lacking [7] .
It is also shown that the stable stem-loop structure downstream to AUG codon can increase the translation efficiency from this AUG codon, especially the AUG codon in a suboptimal context motif [10] . A likely explanation for enhancing effect of a downstream stem-loop structure is that the downstream secondary structure can slow ribosome scanning, thereby providing more time for recognition of the upstream AUG codon and preventing possible leaking scanning from the AUG codon in the suboptimal context motif.
Meanwhile, translation initiation is usually downregulated with a stable upstream stem-loop structure [11, 12] . On one hand, a stable upstream stem-loop structure can impair translation by preventing the ribosomal 40S subunits from engaging to mRNA when the secondary structure occurs near to the 5'-end cap region. On the other hand, a stable upstream stem-loop structure can presumably weaken the migrating ribosomal subunit at this secondary structure, preventing the ribosome from accessing to the downstream AUG codon.
So far, little is known about how the upstream stemloop structure modulates the start codon selection of the mRNA containing adjacent multi-5'-ORF-AUGs. In the current work, we demonstrated that both of the two adjacent 5'-ORF-AUGs of human ACAT1 mRNA could be used as start codons for translation initiation but the first 5'-ORF-AUG 1397-1399 was a main start codon. More interesting, it was also elucidated that a stable upstream stem-loop structure modulated selection of the first 5'-ORF-AUG 1397-1399 as a main start codon for translation initiation of human ACAT1 mRNA.
Materials and Methods

Materials
Cell culture reagents and T4 DNA ligase were purchased from Life Technologies (Rockville, USA). All the restriction enzymes and agarose were from Promega.
Anti-rabbit IgG conjugated with HRP was from Pierce (Rock-ford, USA). ECL detection reagent was from Santa Cruz Biotechnology Inc. (Santa Cruz, USA). Taq DNA polymerase and dNTPs were from Sino-American Biotech (Shanghai, China). All the oligonucleotides were synthesized with an automated DNA synthesizer at Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
Cell culture
The ACAT-deficient mutant cell line (AC29, [10]) derived from CHO was maintained in a basal Ham's F12 medium, supplemented with 10% fetal bovine serum (FBS) and antibiotics, in a humid atmosphere of 5% CO 2 and 95% air at 37 °C.
Expression plasmids
The partial human ACAT1 cDNA K1 sequence (1304-1786 bp) was amplified by PCR using the forward (LDSF, 5'-AGGGCTCGAGGTCGACCTTCCTGCTG-3') and reverse (HAHR, 5'-AAGCGACTCTAGAGGATCGATC-3') primers that contain XhoI or XbaI site (underlined). The amplified fragments (about 500 bp) were then individually purified, digested with XhoI and XbaI, and inserted into the XhoI and XbaI sites of pcDNA3 (Invitrogen) with in-frame downstream stop codon TAG to generate expression plasmid for human ACAT1 Nterminal product, named pcNLD13.
Either or both of the two adjacent AUG codons at 5'-terminus of the open reading frame (ORF) of human ACAT1 mRNA corresponding to cDNA K1 were mutated by a modified two-step PCR method described by Higuchi et al. [13] . Briefly, the first reaction was performed by using the above forward primer LDSF hybridized to 5'-region of the partial human ACAT1 cDNA K1 sequence (1304-1786 bp) inserted into the above constructed expression plasmid, and an internal reverse primer for the desired mutation by mismatched base(s). The second reaction was performed by using an internal forward primer for the same desired mutation by mismatched base(s) and the above reverse primer (HAHR) hybridized to the 3'-end of the partial human ACAT1 cDNA K1 sequence inserted into the above constructed expression plasmid. These two overlapping DNA fragments generated by the above different PCRs are "fused" by denaturing and annealing in a subsequent primer extension reaction. Finally, the "fusion" and extension product was amplified by PCR using LDSF as forward primer and HAHR as reverse primer. An additional AUG codon was inserted directly upstream to the two mutated ORF-AUG codons at 5'-terminus of the open reading frame (ORF) of human ACAT1 mRNA corresponding to partial cDNA K1 (1304-1786 bp) by the two-step PCR. The final PCR products containing the mutated codon(s) were digested with XhoI and XbaI and inserted into the XhoI/XbaI sites of pcDNA3 vector to generate expression plasmid containing partial ACAT1 cDNA K1 sequence (1304-1786 bp) with mutant codon(s) replacing either or both of the first two ORF-AUG codons for human ACAT1 N-terminal product. The related internal reverse/forward primers used and the relevant plasmid names were listed in Table 1 .
The other mutations and deletions of partial human ACAT1 cDNA K1 sequence (1304-1786 bp) were also achieved by using the modified strategy of two-step PCR as above. The final PCR products of partial human ACAT1 cDNA K1 sequence (1304-1786 bp) containing deletion or mutation were digested with XhoI and XbaI and inserted into the XhoI/XbaI sites of pcDNA3 vector to generate expression plasmid for the N-terminal region of human ACAT1. The relative internal reverse and forward primers listed in Table 2 Sequences of internal reverse (R) and forward (F) primers
Sequences of internal reverse (R) and forward (F) primers
The mutated codons were underlined.
Table 3
Internal reverse (R)/forward (F) primers for nucleotide mutations and relevant plasmids Table 2 Internal reverse (R)/forward (F) primers for deletions and relevant plasmids Sequences of internal reverse (R) and forward (F) primers
Plasmid name pcNLD13M45 pcNLD13M46 pcNLD13M47 pcNLD13M48 pcNLD13M51 Table 1 Internal
reverse (R)/forward (F) primers for codon mutations and relevant plasmids
upstream stem-loop structure from 1355 to 1384). All the deletion and mutation plasmids were confirmed by restriction enzyme digestion and DNA sequencing. For enzymatic activity assays, the expression plasmids (pcDNA3A1D4, pcDNA3A1D4M60, pcDNA3A1D4-M61, and pcDNA3A1D4M51) containing partial human ACAT1 cDNA K1 sequence (1304-4011 bp) including the whole ORF sequence (1397-3049 bp) were constructed by substitution of the Bsu36I/XbaI ACAT1 cDNA fragment (1454-4011 bp) for the same Bsu36I/XbaI ACAT1 cDNA fragment (1454-1786 bp) in above constructed expression plasmids (pcNLD13, pcNLD13M45, pcNLD13M48, pcNLD13M51, respectively) containing the partial ACAT1 cDNA K1 sequence (1304-1786 bp).
Transfection
The constructed expression plasmids were individually transfected into AC29 cells by using the method of calcium phosphate co-precipitation described by Liu et al. [14] with slight modifications. Briefly, cells were seeded at density of 5×10 5 cells per 60 mm dish in 5 ml of culture medium containing 10% FBS for 36 h. Cells were then sequentially cultured with fresh medium containing 10% FBS for 2 h and medium without FBS for 30 min before transfection. 1.2 ml of transfection reagent was firstly prepared by gently mixing equal volume of DNA/calcium ions (15 µg DNA for per 60 mm dish and 125 mM calcium ions at final concentration) and HeBS (final concentration: 21 mM HEPES, pH 7.05, 137 mM NaCl, 5 mM KCl, 0.7 mM Na 2 HPO 4 , and 6 mM glucose), then added into medium and incubated with cells at 37 °C for 9 h. After that cells were washed once with PBS, replaced with fresh medium containing 10% FBS, and cultured for another 48 h.
Preparation of protein samples and Western blot analysis
Cells were harvested and lysed with 10% SDS in 50 mM Tris (pH 7.5), 1 mM EDTA (pH 7.5), 50 mM DTT, plus protease inhibitor cocktail (Sigma), incubated at 37 °C and sheared with a syringe fitted with an 18-gauge needle to homogeneity. Protein concentrations of the cell lysates were determined by a modified Lowry method [15] . The protein samples were then subjected to SDS-PAGE. After gel separation, the proteins were transferred to nitrocellulose membrane. The membrane was treated successively at room temperature with 5% milk in TBST (50 mM Tris-HCl, pH 7.6, 0.15 M NaCl, and 0.05% Tween-20) for 2 h, with affinity purified rabbit anti-ACAT1 antibody (DM10) for 3 h, and with HRP-conjugated goat antirabbit antibody for 1 h. After incubation, the membrane was washed extensively with TBST and TBS (50 mM Tris-HCl, pH 7.6, and 0.15 M NaCl), respectively. The immunoreactive band was visualized by using ECL detection reagent.
Enzymatic activity assay
AC29 cells were individually transfected with pcDNA3 and plasmids expressing the human ACAT1 mRNA relative to number 1 to 4 in Fig. 5 
Other methods
Standard molecular biology techniques were performed according to the methods described by Sambrook et al. [17] .
Results
Translation initiation of two adjacent 5'-ORF-AUGs in human ACAT1 mRNA
Human ACAT1 cDNA K1 was first identified from a human macrophage cDNA library by Chang and colleagues [4] . With an in-frame stop codon UAA located at 150 nucleotides upstream to the predicted ORF [ Fig (3 nt before the codon AUG which is numbered 1 to 3) and G +4 (the the nucleotide after the codon AUG which is numbered 1 to 3), which are exactly consistent with those of Kozak sequence [7] , while the flanking nucleotide U +4 of second 5'-ORF-AUG 1415-1417 is not consistent with that of Kozak sequence. This suggests that both of these two adjacent 5'-ORF-AUGs may be used as start codons for translation initiation of human ACAT1 mRNA but the first 5'-ORF-AUG 1397-1399 is more favorable to be selected as a start codon according to Kozak sequence.
To identify the start codon for translation initiation, From these results, it was concluded that both of the two adjacent 5'-ORF-AUGs in human ACAT1 mRNA could be used as start codons for translation initiation, but the first 5'-ORF-AUG 1397-1399 was selected as a main start codon (more than 95%) for ACAT1 expression. The very different efficiencies of translation initiated from these two adjacent 5'-ORF-AUGs [ Fig. 2(B) , lane 1] suggested that 
Fig. 2 Both of two adjacent 5'-ORF-AUGs as start codons for translation initiation of human ACAT1 mRNA
(A) Schematic diagram of the partial human ACAT1 mRNAs (nt 1304-1786, Number 1 to 5) corresponding to cDNA K1 sequences respectively inserted into the expression plasmids pcNLD13, pcNLD13M45, pcNLD13M48, pcNLD13M47 and pcNLD13M46. In number 2 to 5 (mutants), either or both of two adjacent 5'-ORF-AUGs (bold) shown in number 1 (wild type) were replaced by the mutated GCC or UAG (bold and underlined). (B) Western blot analysis. Samples of lane 1 to 5 were individually prepared from AC29 cells transfected with the plasmids expressing wild type and mutants relative to number 1 to 5 in above A. The detailed experimental performances are described under "Materials and Methods". the upstream sequence might contribute to selection of the first 5'-ORF-AUG 1397-1399 as a main start codon by affecting ribosome scanning.
Enhancement of a stable upstream stem-loop structure on selection of the first 5'-ORF-AUG as a main start codon
Therefore, the effect of the upstream sequence [ Fig. 3  (A) ] on the first 5'-ORF-AUG 1397-1399 was further studied by mutation and deletion. Mutating [ Fig. 3(B These evidences demonstrated that a stable upstream stem-loop structure (nt 1355-1384) enhanced the selection of the first 5'-ORF-AUG 1397-1399 as a main start codon for the translation initiation of human ACAT1 mRNA, in addition to A 1394 at the -3 position, which is the same site exactly as Kozak sequence. It also implied that a smaller stem-loop structure which beared the same modulation function as the whole stem-loop structure [ Fig. 4(C,D) , comparing lane 5 with lane 1] could remain active despite the partial sequence deletion [∆1362-1379, Fig. 4(B) , number 5 & Fig. 4(A) ].
Enzymatic activity of ACAT1 initiated respectively from the two adjacent 5'-ORF-AUGs
The above results illustrated that both of the two adjacent 5'-ORF-AUGs of human ACAT1 mRNA could be used as start codons for translation initiation of ACAT1 proteins but the first 5'-ORF-AUG 1397-1399 was selected as a main start codon for ACAT1 expression. So, the 50 kD ACAT1 protein, described previously [4-6], ought to be translated from the first 5'-ORF-AUG [1397] [1398] [1399] , and the ACAT1 protein initiated the translation from the second 5'-ORF-AUG 1415-1417 was predicated about 49 kD due to the difference of 6 amino acid residues (MVGEEK) encoded by the in-frame coding sequence of its upstream 18 nucleotides [ Fig. 1(A) ]. Thereby, it is interesting to investigate whether the enzymatic activities of 50 kD and 49 kD ACAT1s are different. Firstly, expression plasmids The determined enzymatic activities depicted no obvious activity difference between 50 kD and 49 kD ACAT1s, even with a difference of 6 amino acid residues (MVGEEK). This result was consistent with early results that the active site of ACAT1 was located in its C-terminal [18, 19] . Therefore, it was considered that the two adjacent 5'-ORF-AUGs in human ACAT1 mRNA might have evolved at some point during evolution. The partial sequence alignment analysis of ACAT1 or ACAT1-related genes from several species [Fig. 5(D) ] shows that there are two 5'-ORF-AUGs existing in the highly-evolved human and monkey genes but only one 5'-ORF-AUG in the genes of rat and yeast (relevant to the first 5'-ORF-AUG 1397-1399 ) as well as in mouse (relevant to the second 5'-ORF-AUG [1415] [1416] [1417] ). This indicates that two adjacent 5'-ORF-AUGs might occur together in the ACAT1 gene of highly-evolved species.
Discussion
The experimental evidences presented in this work demonstrated that both of the two 5'-ORF-AUGs (the first 5'-ORF-AUG 1397-1399 and the second 5'-ORF-AUG 1415-1417 ) in human ACAT1 mRNA could be used as start codons for the translation initiation, and the first 5'-ORF-AUG [1397] [1398] [1399] was selected as a main start codon (more than 95%) consistent with the start codon in the predicted ORF (1397-3049) of human ACAT1 mRNA corresponding to cDNA K1 [4] .
For the translation initiation from the AUG site, the upstream secondary structure was usually inhibitory by interfering with ribosome binding to mRNA or by blocking ribosome scanning on mRNA [11, 12] . However, in Enzymatic activity assay of ACAT1 proteins initiated from two adjacent 5'-ORF-AUGs (A) Schematic diagram of the partial ACAT1 mRNAs (nt 1304-4011, Number 1 to 4) corresponding to cDNA K1 sequences respectively inserted into expression plasmids pcDNA3A1D4, pcDNA3A1D4M60, pcDNA3A1D4M61 and pcDNA3A1D4M51. Number 1, wild type; Number 2 and 3, two AUG codons were individually replaced by mutated codon GCC (underlined); Number 4, a special control with that both of AUG codons were replaced by mutated codons GCCs (underlined) and the in-frame codon1394 replaced by a AUG codon just upstream of the mutated codon GCC1397 (underlined). (B) Western blot analysis. Samples of lane 1 to 4 were individually prepared from AC29 cells transfected with the plasmids expressing wild type and mutants relative to number 1 to 4 in (A). Sample of lane c was prepared from AC29 cells transfected with vector pcDNA3, and used as control. The detailed experimental performances are described under "Materials and Methods". (C) Normalized ACAT1 enzyme activity. The ACAT1 activities in AC29 cells transfected with the plasmids expressing wild type and mutants relative to number 1 to 4 in above A were determined and normalized by the protein amounts shown in (B). The ACAT activity determination was described in "Experimental Procedures". The data represent one of two separate experiments with the same result. (D) Partial sequence alignment analysis of ACAT1 and ACAT1-related genes from human, monkey, rat, mouse and yeast. The 5'-ORF-AUGs in different species are in bold and underlined. the case of the two adjacent 5'-ORF-AUGs in human ACAT1 mRNA, a stable upstream stem-loop structure (nt 1355-1384) enhanced the selection of the first 5'-ORF-AUG 1397-1399 as a main start codon for the translation initiation of human ACAT1 mRNA, in addition to A 1394 at the -3 position which is the same site exactly as Kozak sequence. Destruction and deletion of this upstream stemloop structure [ Fig. 4(A) , numbers 3 and 4] decreased the amount of 17 kD ACAT1-NTP initiated at the first 5'-ORF-AUG [1397] [1398] [1399] . Meanwhile, a smaller stem-loop structure that bears the same modulation function as the whole stemloop structure [ Fig. 4(C,D) , comparing lane 5 with lane 1] could remain active despite the partial sequence deletion [∆1362-1379, Fig. 4(B) , number 5 & Fig. 4(A) ]. It has been described in some literatures that the stem-loop structures performed their functions by recruiting special factors [20, 21] , hinting that the modulation of upstream stem-loop structure on AUG selection could be fulfilled by recruiting special protein factors binding to the stemloop structure. To our knowledge, little is known about how the upstream stem-loop structure modulates the start codon selection of adjacent multi-5'-ORF-AUGs of the mRNA. The result that a stable upstream stem-loop structure modulated the start codon selection might possess a crucial significance in the translation initiation from a adjacent multi-5'-ORF-AUGs of the mRNA. Elucidating this can also enrich the understanding of the translation initiation of eukaryotic mRNAs.
It was also clarified that the translation of the 50 kD ACAT1, reported early in human cells and transfected AC29 cells [5, 6] , is initiated from the first 5'-ORF-AUG [1397] [1398] [1399] . Translation initiated from the two adjacent 5'-ORFAUGs deduced the 6 amino acid residues difference (MVGEEK) between the 50 and 49 kD products, which were rarely distinguished in SDS-PAGE [ Fig. 5(B) ], while 17 and 16 kD ACAT1-NTPs could be easily separated ( Fig. 3 and 4) . Notwithstanding the 6 amino acid residues difference at their N-termini, 50 and 49 kD products showed almost the same ACAT activities, consisting with the finding that the active site of ACAT1 is in its C-terminal [18, 19] . So, the two adjacent 5'-ORF-AUGs might guarantee the expression of cellular ACAT1, a key and exclusive kind of enzyme catalyzing cholesteryl ester from free cholesterol and fatty acid. Yet, two adjacent 5'-ORF-AUGs of ACAT1 mRNA are found to exist in human and monkey, but only one of AUG codon relative to these two adjacent 5'-ORF-AUGs occurs in the relatively lower-evolved rat, mouse and yeast [ Fig. 5(D) ], demonstrating that the occurrence of two adjacent 5'-ORF-AUGs of ACAT1 mRNA in human and monkey may have happened in evolution. From another point of view, it was also indicated more importance of cellular cholesterol homeostasis and its correlative regulation in highly-evolved human and monkey, which also might be beneficial for intelligence evolution.
